HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

(2010) Richard G. Moore et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

(2009) K Huhtinen et al.   BRITISH JOURNAL OF CANCER

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer

(2009) M. Robyn Andersen et al.   GYNECOLOGIC ONCOLOGY

The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass

(2009) Martina Montagnana et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Ultrasound methods to distinguish between malignant and benign adnexal masses in the hands of examiners with different levels of experience

(2009) C. Van Holsbeke et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review

(2008) Andreas du Bois et al.   GYNECOLOGIC ONCOLOGY

Systematic Evaluation of Candidate Blood Markers for Detecting Ovarian Cancer

(2008) Chana Palmer et al.   PLoS One

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

(2007) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY